Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cunlin Wang

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The Journal of Infectious Diseases|August 21, 2004
Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapyCunlin Wang, David Vlahov, Noya Galai, et al.
AIDS (London, England)|May 21, 2005
The effect of HIV infection on overdose mortalityCunlin Wang, David Vlahov, Noya Galai, et al.
Substance Use & Misuse|March 28, 2008
Mortality risk among recent-onset injection drug users in five U.S. citiesDavid Vlahov, Cunlin Wang, Danielle Ompad, et al.
Clinical and Translational Science|September 4, 2024
Pharmacokinetics of olverembatinib (HQP1351) in the presence of a strong CYP3A4 inhibitor (itraconazole) or inducer (rifampin) in healthy volunteersHengbang Wang, Yun Yang, Zi Chen, et al.
The Journal of Bone and Joint Surgery. American Volume|November 10, 2012
Risk of revision for fixed versus mobile-bearing primary total knee replacementsRobert S Namba, Maria C S Inacio, Elizabeth W Paxton, et al.
JAMA Internal Medicine|February 20, 2013
Sex and risk of hip implant failure: assessing total hip arthroplasty outcomes in the United StatesMaria C S Inacio, Christopher F Ake, Elizabeth W Paxton, et al.
Pharmacoepidemiology and Drug Safety|November 5, 2015
Trends in rates of acetaminophen-related adverse events in the United StatesJacqueline M Major, Esther H Zhou, Hui-Lee Wong, et al.
JAMA|November 18, 2015
Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron ProductsCunlin Wang, David J Graham, Robert C Kane, et al.
JAMA Internal Medicine|October 25, 2016
Association Between Changes in CMS Reimbursement Policy and Drug Labels for Erythrocyte-Stimulating Agents With Outcomes for Older Patients Undergoing Hemodialysis Covered by Fee-for-Service MedicareCunlin Wang, Robert Kane, Mark Levenson, et al.
JAMA Oncology|November 21, 2024
Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib: A Phase 1b Randomized Clinical TrialElias Jabbour, Vivian G Oehler, Paul B Koller, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journal of Infectious Diseases|August 21, 2004
Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapyCunlin Wang, David Vlahov, Noya Galai, et al.
AIDS (London, England)|May 21, 2005
The effect of HIV infection on overdose mortalityCunlin Wang, David Vlahov, Noya Galai, et al.
Substance Use & Misuse|March 28, 2008
Mortality risk among recent-onset injection drug users in five U.S. citiesDavid Vlahov, Cunlin Wang, Danielle Ompad, et al.
Clinical and Translational Science|September 4, 2024
Pharmacokinetics of olverembatinib (HQP1351) in the presence of a strong CYP3A4 inhibitor (itraconazole) or inducer (rifampin) in healthy volunteersHengbang Wang, Yun Yang, Zi Chen, et al.
The Journal of Bone and Joint Surgery. American Volume|November 10, 2012
Risk of revision for fixed versus mobile-bearing primary total knee replacementsRobert S Namba, Maria C S Inacio, Elizabeth W Paxton, et al.
JAMA Internal Medicine|February 20, 2013
Sex and risk of hip implant failure: assessing total hip arthroplasty outcomes in the United StatesMaria C S Inacio, Christopher F Ake, Elizabeth W Paxton, et al.
Pharmacoepidemiology and Drug Safety|November 5, 2015
Trends in rates of acetaminophen-related adverse events in the United StatesJacqueline M Major, Esther H Zhou, Hui-Lee Wong, et al.
JAMA|November 18, 2015
Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron ProductsCunlin Wang, David J Graham, Robert C Kane, et al.
JAMA Internal Medicine|October 25, 2016
Association Between Changes in CMS Reimbursement Policy and Drug Labels for Erythrocyte-Stimulating Agents With Outcomes for Older Patients Undergoing Hemodialysis Covered by Fee-for-Service MedicareCunlin Wang, Robert Kane, Mark Levenson, et al.
JAMA Oncology|November 21, 2024
Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib: A Phase 1b Randomized Clinical TrialElias Jabbour, Vivian G Oehler, Paul B Koller, et al.
Pageof 2